Lung Cancer Clinical Trial

The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy

Summary

CTC levels collected pre-surgery will be correlated with pathological samples.

View Full Description

Full Description

Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will collect demographic and treatment data and explore & describe the pattern of CTC detection in all patients

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with biopsy-proven NSCLC who are undergoing definitive radiotherapy as a part of their treatment regimen.
Age 18 or older
Signed informed consent
Patients who are incapable of providing informed consent are excluded from participating in this study.

Study is for people with:

Lung Cancer

Estimated Enrollment:

153

Study ID:

NCT02135679

Recruitment Status:

Active, not recruiting

Sponsor:

Abramson Cancer Center of the University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Abramson Cancer Center of the University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

153

Study ID:

NCT02135679

Recruitment Status:

Active, not recruiting

Sponsor:


Abramson Cancer Center of the University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider